Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 74

1.

Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistance.

Jensen NF, Stenvang J, Beck MK, Hanáková B, Belling KC, Do KN, Viuff B, Nygård SB, Gupta R, Rasmussen MH, Tarpgaard LS, Hansen TP, Budinská E, Pfeiffer P, Bosman F, Tejpar S, Roth A, Delorenzi M, Andersen CL, Rømer MU, Brünner N, Moreira JM.

Mol Oncol. 2015 Feb 24. pii: S1574-7891(15)00044-7. doi: 10.1016/j.molonc.2015.02.008. [Epub ahead of print]

PMID:
25759163
2.

Impact of adult growth hormone deficiency on daily functioning and well-being.

Brod M, Pohlman B, Højbjerre L, Adalsteinsson JE, Rasmussen MH.

BMC Res Notes. 2014 Nov 18;7:813. doi: 10.1186/1756-0500-7-813.

3.

Cellular disposal of miR23b by RAB27-dependent exosome release is linked to acquisition of metastatic properties.

Ostenfeld MS, Jeppesen DK, Laurberg JR, Boysen AT, Bramsen JB, Primdal-Bengtson B, Hendrix A, Lamy P, Dagnaes-Hansen F, Rasmussen MH, Bui KH, Fristrup N, Christensen EI, Nordentoft I, Morth JP, Jensen JB, Pedersen JS, Beck M, Theodorescu D, Borre M, Howard KA, Dyrskjøt L, Ørntoft TF.

Cancer Res. 2014 Oct 15;74(20):5758-71. doi: 10.1158/0008-5472.CAN-13-3512. Epub 2014 Sep 26.

PMID:
25261234
4.

Acoustically invisible feeding blue whales in Northern Icelandic waters.

Akamatsu T, Rasmussen MH, Iversen M.

J Acoust Soc Am. 2014 Aug;136(2):939-44. doi: 10.1121/1.4887439.

PMID:
25096128
5.

Putative cis-regulatory drivers in colorectal cancer.

Ongen H, Andersen CL, Bramsen JB, Oster B, Rasmussen MH, Ferreira PG, Sandoval J, Vidal E, Whiffin N, Planchon A, Padioleau I, Bielser D, Romano L, Tomlinson I, Houlston RS, Esteller M, Orntoft TF, Dermitzakis ET.

Nature. 2014 Aug 7;512(7512):87-90. doi: 10.1038/nature13602. Epub 2014 Jul 23.

PMID:
25079323
6.

A reversible albumin-binding growth hormone derivative is well tolerated and possesses a potential once-weekly treatment profile.

Rasmussen MH, Olsen MW, Alifrangis L, Klim S, Suntum M.

J Clin Endocrinol Metab. 2014 Oct;99(10):E1819-29. doi: 10.1210/jc.2014-1702. Epub 2014 Jul 11.

PMID:
25013997
7.

Functional screening identifies miRNAs influencing apoptosis and proliferation in colorectal cancer.

Christensen LL, Holm A, Rantala J, Kallioniemi O, Rasmussen MH, Ostenfeld MS, Dagnaes-Hansen F, Øster B, Schepeler T, Tobiasen H, Thorsen K, Sieber OM, Gibbs P, Lamy P, Hansen TF, Jakobsen A, Riising EM, Helin K, Lubinski J, Hagemann-Madsen R, Laurberg S, Ørntoft TF, Andersen CL.

PLoS One. 2014 Jun 3;9(6):e96767. doi: 10.1371/journal.pone.0096767. eCollection 2014.

8.

Assessing the impact of growth hormone deficiency and treatment in adults: development of a new disease-specific measure.

Brod M, Højbjerre L, Adalsteinsson JE, Rasmussen MH.

J Clin Endocrinol Metab. 2014 Apr;99(4):1204-12. doi: 10.1210/jc.2013-3438. Epub 2014 Jan 17.

PMID:
24438372
9.

High expression of microRNA-625-3p is associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancer.

Rasmussen MH, Jensen NF, Tarpgaard LS, Qvortrup C, Rømer MU, Stenvang J, Hansen TP, Christensen LL, Lindebjerg J, Hansen F, Jensen BV, Hansen TF, Pfeiffer P, Brünner N, Ørntoft TF, Andersen CL.

Mol Oncol. 2013 Jun;7(3):637-46. doi: 10.1016/j.molonc.2013.02.016. Epub 2013 Feb 28.

10.

Minke whales maximise energy storage on their feeding grounds.

Christiansen F, Víkingsson GA, Rasmussen MH, Lusseau D.

J Exp Biol. 2013 Feb 1;216(Pt 3):427-36. doi: 10.1242/jeb.074518.

11.

MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer.

Christensen LL, Tobiasen H, Holm A, Schepeler T, Ostenfeld MS, Thorsen K, Rasmussen MH, Birkenkamp-Demtroeder K, Sieber OM, Gibbs P, Lubinski J, Lamy P; COLOFOL steering group, Laurberg S, Oster B, Hansen KQ, Hagemann-Madsen R, Byskov K, Ørntoft TF, Andersen CL.

Int J Cancer. 2013 Jul;133(1):67-78. doi: 10.1002/ijc.28010. Epub 2013 Feb 12.

PMID:
23280316
12.

Overdiagnosis of dementia in young patients - a nationwide register-based study.

Salem LC, Andersen BB, Nielsen TR, Stokholm J, Jørgensen MB, Rasmussen MH, Waldemar G.

Dement Geriatr Cogn Disord. 2012;34(5-6):292-9. doi: 10.1159/000345485. Epub 2012 Nov 30.

PMID:
23208125
13.

Tumor-specific usage of alternative transcription start sites in colorectal cancer identified by genome-wide exon array analysis.

Thorsen K, Schepeler T, Øster B, Rasmussen MH, Vang S, Wang K, Hansen KQ, Lamy P, Pedersen JS, Eller A, Mansilla F, Laurila K, Wiuf C, Laurberg S, Dyrskjøt L, Ørntoft TF, Andersen CL.

BMC Genomics. 2011 Oct 14;12:505. doi: 10.1186/1471-2164-12-505.

14.

Biochemical markers of bone turnover in tibia fracture patients randomly assigned to growth hormone (GH) or placebo injections: Implications for detection of GH abuse.

Krusenstjerna-Hafstrøm T, Rasmussen MH, Raschke M, Govender S, Madsen J, Christiansen JS.

Growth Horm IGF Res. 2011 Dec;21(6):331-5. doi: 10.1016/j.ghir.2011.08.003. Epub 2011 Oct 1.

PMID:
21963127
15.

Evaluation of two commercial global miRNA expression profiling platforms for detection of less abundant miRNAs.

Jensen SG, Lamy P, Rasmussen MH, Ostenfeld MS, Dyrskjøt L, Orntoft TF, Andersen CL.

BMC Genomics. 2011 Aug 26;12:435. doi: 10.1186/1471-2164-12-435.

16.

Normal sweat secretion despite impaired growth hormone-insulin-like growth factor-I axis in obese subjects.

Rasmussen MH, Juul A, Main KM, Hilsted J.

Int J Endocrinol. 2011;2011:493840. doi: 10.1155/2011/493840. Epub 2011 Aug 4.

17.

Long-acting pegylated human GH in children with GH deficiency: a single-dose, dose-escalation trial investigating safety, tolerability, pharmacokinetics and pharmacodynamics.

de Schepper J, Rasmussen MH, Gucev Z, Eliakim A, Battelino T.

Eur J Endocrinol. 2011 Sep;165(3):401-9. doi: 10.1530/EJE-11-0536. Epub 2011 Jul 1.

18.

[Side annotations on X-rays are not always correct].

Rasmussen MH.

Ugeskr Laeger. 2011 Apr 11;173(15):1128-9. Danish.

PMID:
21672465
19.

[Picture of the month: hypertrophic pyloric stenosis].

Rasmussen MH, Kinnander C.

Ugeskr Laeger. 2011 Jun 6;173(23):1659. Danish. No abstract available.

PMID:
21645489
20.

Trouble-shooting deployment and recovery options for various stationary passive acoustic monitoring devices in both shallow- and deep-water applications.

Dudzinski KM, Brown SJ, Lammers M, Lucke K, Mann DA, Simard P, Wall CC, Rasmussen MH, Magnúsdóttir EE, Tougaard J, Eriksen N.

J Acoust Soc Am. 2011 Jan;129(1):436-48. doi: 10.1121/1.3519397.

PMID:
21303023
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk